Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP868609.RAzCgtC0SEf7di3iBvV6uUzVvPQdnN5UsyCgXrFvZ-E5c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP868609.RAzCgtC0SEf7di3iBvV6uUzVvPQdnN5UsyCgXrFvZ-E5c130_assertion type Assertion NP868609.RAzCgtC0SEf7di3iBvV6uUzVvPQdnN5UsyCgXrFvZ-E5c130_head.
- NP868609.RAzCgtC0SEf7di3iBvV6uUzVvPQdnN5UsyCgXrFvZ-E5c130_assertion description "[The current treatment for MPS VI is enzyme replacement therapy (ERT) which has limited efficacy on bone, joints and heart valve disease, as well as high costs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP868609.RAzCgtC0SEf7di3iBvV6uUzVvPQdnN5UsyCgXrFvZ-E5c130_provenance.
- NP868609.RAzCgtC0SEf7di3iBvV6uUzVvPQdnN5UsyCgXrFvZ-E5c130_assertion evidence source_evidence_literature NP868609.RAzCgtC0SEf7di3iBvV6uUzVvPQdnN5UsyCgXrFvZ-E5c130_provenance.
- NP868609.RAzCgtC0SEf7di3iBvV6uUzVvPQdnN5UsyCgXrFvZ-E5c130_assertion SIO_000772 22971959 NP868609.RAzCgtC0SEf7di3iBvV6uUzVvPQdnN5UsyCgXrFvZ-E5c130_provenance.
- NP868609.RAzCgtC0SEf7di3iBvV6uUzVvPQdnN5UsyCgXrFvZ-E5c130_assertion wasDerivedFrom befree-20140225 NP868609.RAzCgtC0SEf7di3iBvV6uUzVvPQdnN5UsyCgXrFvZ-E5c130_provenance.
- NP868609.RAzCgtC0SEf7di3iBvV6uUzVvPQdnN5UsyCgXrFvZ-E5c130_assertion wasGeneratedBy ECO_0000203 NP868609.RAzCgtC0SEf7di3iBvV6uUzVvPQdnN5UsyCgXrFvZ-E5c130_provenance.